Evidence-Based Medicine Guidelines
Glutamatergic drugs for schizophrenia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Glutamatergic Drugs for Schizophrenia." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451138/all/Glutamatergic_drugs_for_schizophrenia.
Glutamatergic drugs for schizophrenia. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/451138/all/Glutamatergic_drugs_for_schizophrenia. Accessed May 30, 2023.
Glutamatergic drugs for schizophrenia. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/451138/all/Glutamatergic_drugs_for_schizophrenia
Glutamatergic Drugs for Schizophrenia [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 May 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451138/all/Glutamatergic_drugs_for_schizophrenia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Glutamatergic drugs for schizophrenia
ID - 451138
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451138/all/Glutamatergic_drugs_for_schizophrenia
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
